119 related articles for article (PubMed ID: 2054268)
1. Influence of acid secretory status on absorption of omeprazole from enteric coated granules.
Andersson T; Bergstrand R; Cederberg C
Br J Clin Pharmacol; 1991 Mar; 31(3):275-8. PubMed ID: 2054268
[TBL] [Abstract][Full Text] [Related]
2. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
Miner PB; Fort JG; Zhang Y
Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
[TBL] [Abstract][Full Text] [Related]
3. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
[TBL] [Abstract][Full Text] [Related]
4. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients.
Thomson AB; Kirdeikis P; Lastiwka R; Röhss K; Sinclair P; Olofsson B
Can J Gastroenterol; 1997; 11(8):657-60. PubMed ID: 9459044
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube.
Larson C; Cavuto NJ; Flockhart DA; Weinberg RB
Dig Dis Sci; 1996 Mar; 41(3):475-9. PubMed ID: 8617118
[TBL] [Abstract][Full Text] [Related]
7. Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules.
Mohiuddin MA; Pursnani KG; Katzka DA; Gideon RM; Castell JA; Castell DO
Dig Dis Sci; 1997 Apr; 42(4):715-9. PubMed ID: 9125637
[TBL] [Abstract][Full Text] [Related]
8. Interaction of omeprazole with enteric-coated salicylate tablets.
Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects.
Andersson T; Andrén K; Cederberg C; Lagerström PO; Lundborg P; Skånberg I
Br J Clin Pharmacol; 1990 May; 29(5):557-63. PubMed ID: 2350532
[TBL] [Abstract][Full Text] [Related]
10. Influence of food on the bioavailability of an enteric-coated tablet formulation of omeprazole 20 mg under repeated dose conditions.
Thomson AB; Sinclair P; Matisko A; Rosen E; Andersson T; Olofsson B
Can J Gastroenterol; 1997; 11(8):663-7. PubMed ID: 9459045
[TBL] [Abstract][Full Text] [Related]
11. Effects of single intravenously administered doses of omeprazole and ranitidine on intragastric pH and plasma gastrin concentration in nonfed ponies.
Baker SJ; Gerring EL
Am J Vet Res; 1993 Dec; 54(12):2068-74. PubMed ID: 8116940
[TBL] [Abstract][Full Text] [Related]
12. Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
Andrews FM; Doherty TJ; Blackford JT; Nadeau JA; Saxton AM
Am J Vet Res; 1999 Aug; 60(8):929-31. PubMed ID: 10451198
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
Sekar VJ; Lefebvre E; De Paepe E; De Marez T; De Pauw M; Parys W; Hoetelmans RM
Antimicrob Agents Chemother; 2007 Mar; 51(3):958-61. PubMed ID: 17210768
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of antiulcer agents in llama.
Christensen JM; Limsakun T; Smith BB; Hollingshead N; Huber M
J Vet Pharmacol Ther; 2001 Feb; 24(1):23-33. PubMed ID: 11348484
[TBL] [Abstract][Full Text] [Related]
15. Nonencapsulated, intact omeprazole granules effectively suppress intragastric acidity when administered via a gastrostomy.
Sharma VK; Heinzelmann EJ; Steinberg EN; Vasudeva R; Howden CW
Am J Gastroenterol; 1997 May; 92(5):848-51. PubMed ID: 9149199
[TBL] [Abstract][Full Text] [Related]
16. Oral bioavailability of omeprazole before and after chronic therapy in patients with duodenal ulcer.
Ching MS; Mihaly GW; Angus PW; Morgan DJ; Devenish-Meares S; Yeomans ND; Smallwood RA
Br J Clin Pharmacol; 1991 Feb; 31(2):166-70. PubMed ID: 2049231
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence between omeprazole MUPS 20 mg as tablet and omeprazole MUPS 20 mg as tablet encapsulated in a hard gelatine capsule.
Schaltenbrand R; Huber R; Cotoraci CA; Mascher H; Potthast H; Hole U
Int J Clin Pharmacol Ther; 2001 Oct; 39(10):453-9. PubMed ID: 11680670
[TBL] [Abstract][Full Text] [Related]
18. Effect of Elevated pH on the Commercial Enteric-Coated Omeprazole Pellets Resistance: Patent Review and Multisource Generics Comparison.
Mohylyuk V; Yerkhova A; Katynska M; Sirko V; Patel K
AAPS PharmSciTech; 2021 Jun; 22(5):188. PubMed ID: 34159427
[TBL] [Abstract][Full Text] [Related]
19. Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidine.
Walker S; Klotz U; Sarem-Aslani A; Treiber G; Bode JC
Digestion; 1991; 48(3):179-84. PubMed ID: 1916039
[TBL] [Abstract][Full Text] [Related]
20. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
